Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/10/2017
SIETES contiene 92082 citas

 
 
 1 a 20 de 67 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Gieling EM, van den Ham HA, van Onzenoort H, Bos J, Kramers C, de Boer A, de Vries F, Burden AM. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study. Br J Clin Pharmacol 2017;83:1844-59. [Ref.ID 102014]
2. Cita con resumen
Perreault S, de Denus S, White M, White-Guay B, Bouvier M, Dorais M, Dubé M-P, Rouleau J-L, Tardif J-C, Jenna S, Haibe-Kains B, Leduc R, Deblois D. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality. Pharmacoepidemiol Drug Saf 2017;26:81-90. [Ref.ID 101948]
3. Cita con resumen
Johnston SC, Amarenco P, Albers GW, Denison H, Easton D, Evans SR, Held P, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KSL, for the SOCRATES Steering Committee and Investigators. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med 2016;375:35-43. [Ref.ID 100628]
4. Cita con resumen
Anónimo. Comparative effectiveness of proton pump inhibitors. Therapeutics Initiative Evidence Based Drug Therapy 2016;99:1-2. [Ref.ID 100573]
5. Cita con resumen
Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suárez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 2016;164:740-51. [Ref.ID 100415]
7. Cita con resumen
Geisler WM, Uniyal A, Lee JY, Lensing SY, Johnson S, Perry RCW, Kadrnka CM, Kerndt PR. Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection. N Engl J Med 2015;373:2512-21. [Ref.ID 99766]
8. Cita con resumen
Khanna R, Bressler B, Levesque BG, Zou G, Sitt LW, Greenberg GR, Panaccione R, Bitton A, Paré P, Vermeire S, D'Haens G, Macintosh D, Sandborn WJ, Donner A, Vandervoort MK, Morris JC, Feagan BG, REACT Study Investigators. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial. Lancet 2015;386:1825-34. [Ref.ID 99669]
9. Cita con resumen
Naci H, Carter AW, Mossialos E. Why the drug development pipeline is not delivering better medicines. BMJ 2015;351:h5542. [Ref.ID 99639]
10. Cita con resumen
Bannuru RR, McAlindon TE, Sullivan MC, Wong JB, Kent DM, Schmid CH. Effectiveness and Implications of alternative placebo treatments: A systematic review and network meta-analysis of osteoarthritis trials. Ann Intern Med 2015;163:365-72. [Ref.ID 99463]
11.Tiene citas relacionadas
Dalgleish S. Safety of new anticoagulants in high risk patients. BMJ 2014;348:g1861. [Ref.ID 97350]
12.Tiene citas relacionadas Cita con resumen
Hoffman KB, Demakas A, Erdman CB, Dimbil M. Post-approval adverse events of new and old anticoagulants. BMJ 2014;348:g1859. [Ref.ID 97349]
13.Enlace a cita original
Reams BD, O'Malley CD, Critchlow CW, Lauffenburger JC, Brookhart MA. Changing patterns of use of osteoporosis medications in the years after launch: implications for comparative effectiveness research. Pharmacoepidemiol Drug Saf 2014;23:251-60. [Ref.ID 97274]
14.Tiene citas relacionadas Cita con resumen
Reith C, Landray M, Califf RM. Randomized clinical trials - Removing obstacles. N Engl J Med 2013;369:2269. [Ref.ID 96620]
15.Tiene citas relacionadas Cita con resumen
Galbraith KL. Randomized clinical trials - Removing obstacles. N Engl J Med 2013;369:2268-9. [Ref.ID 96619]
16.Enlace a cita originalTiene citas relacionadas
Zaccara G, Sisodiya SM, Giovannelli F, Walker MC, Heaney DC, Angus-Leppan H, Wehner T, Eriksson SH, Liu R, Rugg-Gunn F, Shorvon SD, Sander JW. Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy. Br J Clin Pharmacol 2013;76:827-8. [Ref.ID 96485]
17.Enlace a cita originalTiene citas relacionadas
Bodalia PN, Grosso AM, Sofat R, MacAllister R, Smeeth L, Dhillon S, Casas J-P, Wonderling D, Hingorani AD. Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials. Br J Clin Pharmacol 2013;76:649-67. [Ref.ID 96479]
18.Enlace a cita originalTiene citas relacionadas
Brodie MJ. Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation. Br J Clin Pharmacol 2013;76:630-1. [Ref.ID 96478]
19.
Barbui C, Bigheli I. A new approach to psychiatric drug approval in Europe. PLOS Medicine 2013:15 de octubre. [Ref.ID 96363]
20.Tiene citas relacionadas
Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951-62. [Ref.ID 96106]
Seleccionar todas
 
 1 a 20 de 67 siguiente >>